Loading clinical trials...
Loading clinical trials...
Effectiveness of Novel Bioactive Glass in the Treatment of Enamel White Spot Lesions : A Randomized Controlled Trial
the aim of this study is to evaluate the effectiveness of BiominF® and Novamin® in comparison to Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) in the treatment of enamel white spot lesions
Age
14 - 26 years
Sex
ALL
Healthy Volunteers
Yes
Faculty of Dentistry
Alexandria, Egypt
Start Date
June 1, 2020
Primary Completion Date
June 30, 2021
Completion Date
June 30, 2021
Last Updated
October 19, 2021
60
ACTUAL participants
BiominF
DRUG
Novamin
DRUG
CPP-ACP
DRUG
Lead Sponsor
Rania Salah
Collaborators
NCT06986551
NCT06797882
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions